These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14501158)

  • 1. Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.
    Abe Y; Aoyagi A; Hara T; Abe K; Yamazaki R; Kumagae Y; Naruto S; Koyama K; Marumoto S; Tago K; Toda N; Takami K; Yamada N; Ori M; Kogen H; Kaneko T
    J Pharmacol Sci; 2003 Sep; 93(1):95-105. PubMed ID: 14501158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
    Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T; Kogen H
    Bioorg Med Chem; 2003 May; 11(9):1935-55. PubMed ID: 12670645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter.
    Toda N; Kaneko T; Kogen H
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):273-87. PubMed ID: 20190429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease.
    Toda N; Tago K; Marumoto S; Takami K; Ori M; Yamada N; Koyama K; Naruto S; Abe K; Yamazaki R; Hara T; Aoyagi A; Abe Y; Kaneko T; Kogen H
    Bioorg Med Chem; 2003 Oct; 11(20):4389-415. PubMed ID: 13129577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Smith CP; Bores GM; Petko W; Li M; Selk DE; Rush DK; Camacho F; Winslow JT; Fishkin R; Cunningham DM; Brooks KM; Roehr J; Hartman HB; Davis L; Vargas HM
    J Pharmacol Exp Ther; 1997 Feb; 280(2):710-20. PubMed ID: 9023283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 1999 Sep; 380(2-3):101-7. PubMed ID: 10513568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DL0410 Ameliorates Memory and Cognitive Impairments Induced by Scopolamine via Increasing Cholinergic Neurotransmission in Mice.
    Lian W; Fang J; Xu L; Zhou W; Kang D; Xiong W; Jia H; Liu AL; Du GH
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
    Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
    Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
    J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
    Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
    J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHF2819: pharmacological profile of a novel acetylcholinesterase inhibitor.
    Trabace L; Cassano T; Loverre A; Steardo L; Cuomo V
    CNS Drug Rev; 2002; 8(1):53-69. PubMed ID: 12070526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DKP cyclo(L-Phe-L-Phe) found in chicken essence is a dual inhibitor of the serotonin transporter and acetylcholinesterase.
    Tsuruoka N; Beppu Y; Koda H; Doe N; Watanabe H; Abe K
    PLoS One; 2012; 7(11):e50824. PubMed ID: 23209830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats.
    Demir Özkay Ü; Can ÖD; Sağlık BN; Turan N
    Pharmacol Rep; 2017 Dec; 69(6):1349-1356. PubMed ID: 29132093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.
    Kosasa T; Kuriya Y; Matsui K; Yamanishi Y
    Eur J Pharmacol; 2000 Feb; 389(2-3):173-9. PubMed ID: 10688981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and neurobehavioral profile of CHF2819, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
    Trabace L; Cassano T; Steardo L; Pietra C; Villetti G; Kendrick KM; Cuomo V
    J Pharmacol Exp Ther; 2000 Jul; 294(1):187-94. PubMed ID: 10871311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.
    Barnes CA; Meltzer J; Houston F; Orr G; McGann K; Wenk GL
    Neuroscience; 2000; 99(1):17-23. PubMed ID: 10924948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.
    Hernandez CM; Gearhart DA; Parikh V; Hohnadel EJ; Davis LW; Middlemore ML; Warsi SP; Waller JL; Terry AV
    J Pharmacol Exp Ther; 2006 Feb; 316(2):679-94. PubMed ID: 16214877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice.
    Cachard-Chastel M; Devers S; Sicsic S; Langlois M; Lezoualc'h F; Gardier AM; Belzung C
    Behav Brain Res; 2008 Mar; 187(2):455-61. PubMed ID: 18061284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease.
    Ahmed T; Gilani AH
    Pharmacol Biochem Behav; 2009 Feb; 91(4):554-9. PubMed ID: 18930076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice.
    Liu W; Zhu Y; Wang Y; Qi S; Wang Y; Ma C; Li S; Jiang B; Cheng X; Wang Z; Xuan Z; Wang C
    J Ethnopharmacol; 2017 May; 204():95-106. PubMed ID: 28442406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.